Available Reports

Medicare Performance and Cost Discipline Drive Raised FY2026 EPS Outlook to $19.50-$20.00 FY2026 Q2 | Jul 17, 2026

Adjusted EPS Guidance Raised After Q1 Exceeds Plan; MCR Improves Year-Over-Year FY2026 Q1 | Apr 22, 2026

FY26 Guidance Formalizes Reset, Targeting Over 8.6% Adjusted EPS Growth Through Strategic Contraction of 2.3-2.8 Million Members FY2025 Q4 | Jan 28, 2026

Full-Year 2025 Guidance Raised Amid Strategic Contraction; Medicare Advantage Membership to Decline by ~1M in 2026 to Restore Margins FY2025 Q3 | Oct 29, 2025

Outlook Cut Sharply as 2025 Medical Cost Trend Hits 7.5%; New Leadership Pivots to Margin Recovery & Plan Exits FY2025 Q2 | Sep 13, 2025

FY2025 Outlook Sharply Lowered as Medicare Advantage Utilization Surges and Optum Health Faces Revenue Headwinds FY2025 Q1 | Sep 13, 2025

2025 Outlook Affirmed as Cost Pressures Stabilize; PBM Rebate Pass-Through Commitment Signals Strategic Shift on Drug Pricing FY2024 Q4 | Sep 13, 2025

Preliminary 2025 Adj. EPS Outlook Reset to ~$30 as Specialty Drug and Coding Headwinds Intensify in Government Programs FY2024 Q3 | Sep 13, 2025

Full-Year Adjusted EPS Outlook Affirmed as Operational Efficiencies Absorb Increased Cyberattack Costs FY2024 Q2 | Sep 13, 2025

Adjusted EPS Guidance Reaffirmed as Core Operations Absorb $872M Cyberattack Impact in Q1 FY2024 Q1 | Sep 13, 2025

Medicare Performance and Cost Discipline Drive Raised FY2026 EPS Outlook to $19.50-$20.00

Sign in required

dbot

UnitedHealth Group Incorporated - Reports

Available Reports

Medicare Performance and Cost Discipline Drive Raised FY2026 EPS Outlook to $19.50-$20.00

Sign in required